The case pertains to an application filed under Section 30(6) of the Insolvency & Bankruptcy Code, 2016 by the Resolution Professional of the corporate debtor, Saffron Therapeutics Private Limited. The application seeks the approval of a resolution plan submitted by the successful resolution applicant, Mr. Amit Singh. The Corporate Insolvency Resolution Process (CIRP) was initiated following an insolvency application filed by a financial creditor under Section 7 of the Code. The Committee of Creditors (CoC) comprised of one financial creditor, Gusaiji Trading Private Limited, holding 100% voting share. The resolution plan was approved by the CoC with 100% votes in favor.
The Corporate Insolvency Resolution Process (CIRP) was initiated against Saffron Therapeutics Private Limited following an application by a financial creditor under Section 7 of the Insolvency and Bankruptcy Code (IBC), 2016. The application was admitted on 25.09.2023, and Mr. Omkarchand Rikhabdas Maloo was appointed as the Interim Resolution Professional (IRP). A public announcement was made on 27.09.2023, inviting claims from creditors, with a deadline of 09.10.2023. The Committee of Creditors (CoC) was constituted on 18.10.2023, comprising Gusaiji Trading Private Limited as the sole financial creditor with 100% voting share, as other creditors were related parties. The first CoC meeting was held on 25.10.2023, where Mr. Omkarchand Rikhabdas Maloo was appointed as
…Sign in to view the parties.
The insolvency…
Public announcement…
The case pertains to an application filed under Section 30(6) of the Insolvency & Bankruptcy Code, 2016 by the Resolution Professional of the corporate debtor, Saffron Therapeutics Private Limited. The application seeks the approval of a resolution plan submitted by the successful resolution applicant, Mr. Amit Singh. The Corporate Insolvency Resolution Process (CIRP) was initiated following an insolvency application filed by a financial creditor under Section 7 of the Code. The Committee of Creditors (CoC) comprised of one financial creditor, Gusaiji Trading Private Limited, holding 100% voting share. The resolution plan was approved by the CoC with 100% votes in favor.
The Corporate Insolvency Resolution Process (CIRP) was initiated against Saffron Therapeutics Private Limited following an application by a financial creditor under Section 7 of the Insolvency and Bankruptcy Code (IBC), 2016. The application was admitted on 25.09.2023, and Mr. Omkarchand Rikhabdas Maloo was appointed as the Interim Resolution Professional (IRP). A public announcement was made on 27.09.2023, inviting claims from creditors, with a deadline of 09.10.2023. The Committee of Creditors (CoC) was constituted on 18.10.2023, comprising Gusaiji Trading Private Limited as the sole financial creditor with 100% voting share, as other creditors were related parties. The first CoC meeting was held on 25.10.2023, where Mr. Omkarchand Rikhabdas Maloo was appointed as
…The insolvency…
Public announcement…